Skip to content

Assessing Construction Execution Under Sleep Impairment

Feasibility of VR Construction Simulations for Detecting Sleep-Related Impairments

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07431970
Acronym
ACES
Enrollment
12
Registered
2026-02-25
Start date
2026-03-01
Completion date
2026-08-31
Last updated
2026-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep

Keywords

Occupational Health, Construction, Sleep, Virtual Reality, Sleep Impairment

Brief summary

The goal of this study is to learn whether virtual reality (VR) construction tasks can detect performance changes associated with prior sleep, and to determine the extent to which these changes can be distinguished from interacting repetitively with VR itself.

Detailed description

After passing a physical assessment and psychological screen, up to 12 participants will be enrolled. Ahead of each 8-hour in-laboratory assessment, participants will be asked to participate in a 1-week at-home monitoring period while continuing with their regular sleep/wake schedule. During this at-home assessment participants will be asked to wear an ActiGraph to objectively assess sleep and complete daily sleep diaries and call into a time-stamped voice-mailbox when going to bed and getting out of bed to confirm sleep/wake times. Participants will be asked to refrain from any alcohol, substances, or intense physical activity during each 1-week at home monitoring period. Similarly, participants are asked to refrain from caffeine consumption 5h prior to the in lab. Participants will then participate in two 8-hour sessions in an in-laboratory setting with a 1-week washout period in-between each in-laboratory visit. The two 8-hour visits will be identical in schedule and instrumentation, differing only in whether VR tasks are administered. Order of visits will be randomized. At each visit, participants will arrive to the laboratory \ 6h after their habitual waketime (determined from daily call-ins) and be hooked up for ECG and beat-by-beat blood pressure. They will wear an ActiGraph the entire in-laboratory visit. Participants will also be asked to complete the Karolinska Sleepiness Scale (KSS) questionnaire and the modified Positive Affect-Negative Affect Schedule (PANAS) and the Profile of Mood States (POMS) questionnaire. Finally, participants will be asked to complete construction virtual reality tasks using a virtual reality headset during each of the 4 time points at each visit.

Interventions

OTHERConstruction Virtual Reality Stress Challenges

Participants will be randomly assigned to a laboratory visit that will contain construction virtual reality stress challenges.

OTHERNo Construction Virtual Reality Stress Challenges

Participants will be randomly assigned to a laboratory visit that will not contain construction virtual reality stress challenges.

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Intervention model description

Participants will be randomized to participate in construction virtual reality tasks on visit 1 or visit 2.

Eligibility

Sex/Gender
ALL
Age
21 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* Fluent in English * Tolerate virtual reality system

Exclusion criteria

* Recent shiftwork * Recent travel across time zones (\>2 in last month) * Underlying health conditions (high blood pressure, diabetes, cancer, heart attack, heart failure, angioplasty, heart surgery, etc.) * Use of nicotine products such as tobacco or e-cigarettes * Use of illicit drugs in the past year * Pregnancy * Sleep disorders (obstructive sleep apnea)

Design outcomes

Primary

MeasureTime frameDescription
Feasibility: RecruitmentFrom first date of recruitment activities to last day of study activities, up to 100 weeks.Number of eligible participants who enroll in the study.
Feasibility: RetentionFrom start of recruitment activities to the end of study activities, up to 100 weeks.Proportion of eligible participants who enroll and complete all scheduled study visits.
Feasibility: Tolerability of Repeated VR use and Physiologic MonitoringAssessed each 8-hour in laboratory visitProportion of participants able to complete repeated VR tasks and physiologic monitoring without early discontinuation due to discomfort, cybersickness, or adverse symptoms.
Feasibility: Data Completeness and QualityThrough study completion, an average of 1 yearProportion of planned VR task sessions and physiologic recordings successfully completed with usable data.

Secondary

MeasureTime frameDescription
Instruction Re-Engagement During VR TasksAssessed during each 8-hour in-laboratory visit.Number of times participants revisit or request task instructions during construction-related VR tasks.
Task Resumption Time Following DisruptionAssessed during each 8-hour in-laboratory visit.Time (seconds) required for participants to resume task engagement following an interruption or distraction during VR tasks.
VR Task Completion TimeAssessed during each 8-hour in-laboratory visit.Time required to complete construction-related VR tasks.
Movement Efficiency During VR TasksAssessed during each 8-hour in-laboratory visit.Movement efficiency metrics during VR tasks, including the number of movements required to manipulate objects or complete task objectives.
Controller Interaction MetricsAssessed during each 8-hour in-laboratory visit.Controller interaction characteristics during VR tasks, including grip engagement and input patterns.
Gaze Behavior During VR TasksAssessed during each 8-hour in-laboratory visit.Gaze behavior during VR tasks assessed via eye tracking, including fixation duration and spatial distribution of gaze points.
Subjective Sleepiness4 Time Points during each 8-hour in-laboratory visitThe Karolinska Sleepiness Scale (KSS) with responses 1 (Extremely alert) to 10 (Extremely sleepy, can't keep awake) will assess subjective sleepiness
Positive AffectAssessed at four time points during each 8-hour in-laboratory visit.Positive affect assessed using the Positive Affect subscale of the Positive and Negative Affect Schedule (PANAS). The Positive Affect subscale consists of 10 items rated on a 5-point Likert scale (1 = very slightly or not at all to 5 = extremely), with total scores ranging from 10 to 50. Higher scores indicate greater positive affect.
Negative AffectAssessed at four time points during each 8-hour in-laboratory visit.Negative affect assessed using the Negative Affect subscale of the Positive and Negative Affect Schedule (PANAS). The Negative Affect subscale consists of 10 items rated on a 5-point Likert scale (1 = very slightly or not at all to 5 = extremely), with total scores ranging from 10 to 50. Higher scores indicate greater negative affect.
Mood DisturbanceAssessed at four time points during each 8-hour in-laboratory visit.Mood disturbance assessed using the Profile of Mood States (POMS). The POMS evaluates multiple mood domains (e.g., tension-anxiety, depression-dejection, anger-hostility, vigor, fatigue, confusion). A Total Mood Disturbance (TMD) score is calculated by summing negative mood subscales and subtracting the vigor score. TMD scores typically range from approximately -20 to 100, depending on the version used. Higher scores indicate greater overall mood disturbance, while lower or negative scores indicate more favorable mood states.
Parasympathetic activityAssessed during each 8-hour in-laboratory visit.Assessed using the high frequency power (HF) of the HRV power spectrum (collected from cleaned ECG using Kubios) to estimate cardiac parasympathetic activity as modulated by respiratory sinus arrhythmia during the time of seated rest noted above (but first 5 minutes consistent with field standards).
Systolic Blood PressureAssessed during each 8-hour in-laboratory visit.Will be measured beat-to-beat using a non-invasive device employing the volume-clamp method with hydrostatic correction with measures on alternating fingers every 15 min (NIBP).
Diastolic Blood PressureAssessed during each 8-hour in-laboratory visit.Will be measured beat-to-beat using a non-invasive device employing the volume-clamp method with hydrostatic correction with measures on alternating fingers every 15 min (NIBP).
Electrodermal activityAssessed during each 8-hour in-laboratory visit.Continuously assessed using galvanic skin response (GSR) electrodes attached to a fully isolated low voltage amplifier (AD Instruments Ltd). GSR electrodes will be attached to the distal phalange of the index and middle fingers of the non-dominant hand via supplied Velcro tape.

Countries

United States

Contacts

CONTACTNicole P Bowles, PhD
bowlesn@ohsu.edu503-494-2541

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026